Directory
>
Meredith Goldwasser
Meredith Goldwasser
Senior Vice President, Head of Strategy and Corporate Operations | Prime Medicine, Inc.
Cambridge, Massachusetts, United States
Meredith Goldwasser
Summary
Meredith Goldwasser is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as the Senior Vice President and Head of Strategy and Corporate Operations at Prime Medicine, she has a strong background in oncology business development and biostatistics. With a career spanning over two decades, she has held key positions at major firms including Agios Pharmaceuticals, Novartis, Genentech, and Dana Farber Cancer Institute. Meredith holds a ScD in Biostatistics from Harvard University and a BA from the University of Pennsylvania. Her expertise lies in strategic planning and operational leadership within the life sciences industry. Beyond her professional achievements, she is passionate about advancing healthcare innovations and improving patient outcomes. Meredith's analytical skills and leadership capabilities make her a valuable asset in driving organizational success in a rapidly evolving field.
Meredith Goldwasser
Work Experience
Senior Vice President, Head of Strategy and Corporate Operations at
Prime Medicine, Inc.
September 2020 - Present
Vice President, Clinical Development, IDH Hematology Development Lead at
Agios Pharmaceuticals
November 2017 - September 2020
Oncology Business Development at
Agios Pharmaceuticals
July 2019 - September 2020
Vice President, Head of Biometrics & Data Management at
Agios Pharmaceuticals
August 2014 - July 2019
US Group Head, Biostatistics, Oncology Translational Medicine at
Novartis
February 2011 - July 2014
Senior Biostatistician, BioOncology at
Genentech Foundation
January 2006 - January 2009
Research Scientist, Biostatistics at
Dana-Farber Cancer Institute
January 2003 - January 2006
Meredith Goldwasser
Education
University of Pennsylvania, Ba
Harvard University, Scd
Frequently Asked Questions about Meredith Goldwasser
What is Meredith Goldwasser email address?
Meredith Goldwasser's primary email address is ***********@primemedicine.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Meredith Goldwasser work for?
Meredith Goldwasser is a Senior Vice President, Head of Strategy and Corporate Operations at Prime Medicine, Inc..
Where Meredith Goldwasser graduated from?
Meredith Goldwasser holds a degree in from University of Pennsylvania.
How can I directly contact Meredith Goldwasser?
To contact Meredith Goldwasser directly, you can use the email address ***********@primemedicine.com. Complete contact information is available upon registration with Muraena.
Who is Meredith Goldwasser?
Meredith Goldwasser is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as the Senior Vice President and Head of Strategy and Corporate Operations at Prime Medicine, she has a strong background in oncology business development and biostatistics. With a career spanning over two decades, she has held key positions at major firms including Agios Pharmaceuticals, Novartis, Genentech, and Dana Farber Cancer Institute. Meredith holds a ScD in Biostatistics from Harvard University and a BA from the University of Pennsylvania. Her expertise lies in strategic planning and operational leadership within the life sciences industry. Beyond her professional achievements, she is passionate about advancing healthcare innovations and improving patient outcomes. Meredith's analytical skills and leadership capabilities make her a valuable asset in driving organizational success in a rapidly evolving field.
Meredith`s contact details
***********@primemedicine.com
Colleagues
Chief Technical Officer
Vice President, Nonclinical Development at Prime Medicine
Venture Advisor
Chief HR Officer at Prime Medicine
VP Business Development
Vice President
Chief Accounting Officer and SVP Finance
President and Chief Executive Office
Senior Vice President, Head of Regulatory Affairs
Vice President and Head of Hematology & Immunology